Federal Register #DEA-1604

DEA Schedules Four Synthetic Cannabinoids as Schedule I Controlled Substances

This regulatory action by the Drug Enforcement Administration (DEA) under the Department of Justice permanently places four synthetic cannabinoids into Schedule I of the Controlled Substances Act: - Government Buyer: - Department of Justice, Drug Enforcement Administration (DEA) - OEMs and Vendors: - No commercial OEMs or vendors are referenced; DEA is the issuing authority - Products/Services Affected: - 4F-MDMB-BUTICA (also known as 4F-MDMB-BICA) - ADB-4en-PINACA - 5F-EDMB-PICA (also known as 5F-EDMB-2201) - MMB-FUBICA - These are chemical substances, not commercial products for procurement - Regulatory Requirements: - Strict controls on manufacture, distribution, import, export, research, and possession - Requirements for registration, security, labeling, quotas, inventory, order forms, import/export, and reporting - Applies to all individuals and entities handling these substances - Notable Details: - No procurement of goods or services is being solicited or awarded - This is a permanent scheduling action with no end date - The substances are classified as having high abuse potential, no accepted medical use, and lack of safety under medical supervision

Description

The Drug Enforcement Administration (DEA) issues a final rule placing four synthetic cannabinoids—4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA—into Schedule I of the Controlled Substances Act. This classification imposes regulatory controls and administrative, civil, and criminal sanctions on persons who manufacture, distribute, import, export, research, or possess these substances. The rule includes provisions for handling, security, labeling, quota, inventory, order forms, importation, exportation, and liability related to these substances. The rule is effective May 1, 2026, and aims to address public safety concerns associated with these synthetic drugs.

View original listing